World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT03392857
Date of registration: 18/12/2017
Prospective Registration: Yes
Primary sponsor: French Society for Intensive Care
Public title: End Of Life in the Critically Ill patiEnt EOLE
Scientific title: End Of Life in the Critically Ill patiEnt
Date of first enrolment: March 28, 2018
Target sample size: 514
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT03392857
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
Belgium Canada France Monaco Tunisia
Contacts
Name:     Florence Boissier, MD
Address: 
Telephone:
Email:
Affiliation:  French Intensive Care Society
Key inclusion & exclusion criteria

Inclusion Criteria:

- Caregivers of intensive care unit whose patient has recently deceased

Exclusion Criteria:

- Refusal of participation by caregivers

- Refusal of participation by family of deceased patient

- Patient in cardiac arrest at the time of ICU admission.

- Age of deceased patient was under 18 years

- Patient in brain death



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Terminal Illness
Intensive Care Unit Syndrome
Intervention(s)
Other: Assessment by caregivers of the quality of the end of life in intensive care units
Primary Outcome(s)
15 items questionnaire CAESAR [Time Frame: Depending of end-of-life duration, usually 6 hours.]
Secondary Outcome(s)
Variables associated with the perception by caregivers of end-of-life quality [Time Frame: time needed for the enrollment of caregivers of 5 to 15 consecutive deceased patients per center (depending on the size of the center): usually 1 month]
Analogic visual scale (0 to 10) [Time Frame: Depending of end-of-life duration, usually 6 hours.]
Secondary ID(s)
EOLE
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
CHU Nantes
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history